Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Tan

Showing results (1031-1040 of 1,101) with videos related to

Pageof 111
Sort By:
Nature Communications|October 20, 2025
Mosquito salivary sialokinin reduces monocyte activation and chikungunya virus-induced inflammation via neurokinin receptorsSiew-Wai Fong, Jeslin J L Tan, Vaishnavi Sridhar, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2025
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancerStephanie P L Saw, Angela Takano, Siqin Zhou, et al.
Cancer Research Communications|June 28, 2023
Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast CancerXuemei Xie, Gaurav B Chauhan, Ramakrishna Edupuganti, et al.
Contemporary Clinical Trials|October 24, 2015
Lumbar Imaging With Reporting Of Epidemiology (LIRE)--Protocol for a pragmatic cluster randomized trialJeffrey G Jarvik, Bryan A Comstock, Kathryn T James, et al.
Biomaterials|June 14, 2019
Hepatic spheroids used as an in vitro model to study malaria relapseAdeline C Y Chua, Abhishek Ananthanarayanan, Jessica Jie Ying Ong, et al.
Science Advances|January 21, 2026
A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC)Yafei Du, Wenjing Wang, Hui Chin Goh, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2022
PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancerStephanie P L Saw, Win Pin Ng, Siqin Zhou, et al.
The Lancet. Oncology|October 3, 2024
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trialJürgen Wolf, Maximilian Hochmair, Ji-Youn Han, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2024
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLCStephanie P L Saw, Yi Fen Low, Gillianne G Y Lai, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 25, 2019
[The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma]W J Ni, W Deng, Z F Xiao, et al.
Pageof 111

Showing results (1031-1040 of 1,101) with videos related to

Sort By:
Pageof 111
Nature Communications|October 20, 2025
Mosquito salivary sialokinin reduces monocyte activation and chikungunya virus-induced inflammation via neurokinin receptorsSiew-Wai Fong, Jeslin J L Tan, Vaishnavi Sridhar, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2025
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancerStephanie P L Saw, Angela Takano, Siqin Zhou, et al.
Cancer Research Communications|June 28, 2023
Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast CancerXuemei Xie, Gaurav B Chauhan, Ramakrishna Edupuganti, et al.
Contemporary Clinical Trials|October 24, 2015
Lumbar Imaging With Reporting Of Epidemiology (LIRE)--Protocol for a pragmatic cluster randomized trialJeffrey G Jarvik, Bryan A Comstock, Kathryn T James, et al.
Biomaterials|June 14, 2019
Hepatic spheroids used as an in vitro model to study malaria relapseAdeline C Y Chua, Abhishek Ananthanarayanan, Jessica Jie Ying Ong, et al.
Science Advances|January 21, 2026
A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC)Yafei Du, Wenjing Wang, Hui Chin Goh, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2022
PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancerStephanie P L Saw, Win Pin Ng, Siqin Zhou, et al.
The Lancet. Oncology|October 3, 2024
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trialJürgen Wolf, Maximilian Hochmair, Ji-Youn Han, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2024
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLCStephanie P L Saw, Yi Fen Low, Gillianne G Y Lai, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 25, 2019
[The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma]W J Ni, W Deng, Z F Xiao, et al.
Pageof 111